Regeneron Pharmaceuticals
(NASDAQ:REGN)
$695.01
At close: Sep 27
$695.01
PreMarket: 4:43PM EDT
Day Range- - -52 Wk Range538.01 - 754.67Open / Close- / -Float / Outstanding102.6M / 109M
Vol / Avg.- / 670.2KMkt Cap75.8BP/E13.9150d Avg. Price631.19
Div / Yield-Payout Ratio-Total Float102.6MEPS7.9

Regeneron Pharmaceuticals Stock (NASDAQ:REGN), Quotes and News Summary

Regeneron Pharmaceuticals Stock (NASDAQ: REGN)

Day Range- - -52 Wk Range538.01 - 754.67Open / Close- / -Float / Outstanding102.6M / 109M
Vol / Avg.- / 670.2KMkt Cap75.8BP/E13.9150d Avg. Price631.19
Div / Yield-Payout Ratio-Total Float102.6MEPS7.9
Sector: Health Care.Industry: Biotechnology
Regeneron Pharmaceuticals discovers, develops, and commercializes products that fight eye disease, cardiovascular disease, cancer, and inflammation. The company has several marketed products, including Eylea, approved for wet age-related macular degeneration and other eye diseases; Praluent for LDL cholesterol lowering; Dupixent in immunology; Libtayo in oncology; and Kevzara in rheumatoid arthritis. Regeneron is also developing monoclonal and bispecific antibodies with Sanofi, other collaborators, and independently, and has earlier-stage partnerships that bring new technology to the pipeline, including RNAi (Alnylam) and CRISPR-based gene editing (Intellia).

Earnings

see more
Q3 2022Est.ActualSurprise
EPS
(EXPECTED)2022-11-03
REV
Q2 2022Est.ActualSurprise
EPS9.5409.770 0.2300
REV2.790B2.857B67.000M

Analyst Ratings

see more
DateAnalyst FirmAnalyst NameActionRatingAction Price Prior Price Target

Regeneron Pharmaceuticals Questions & Answers

Q
How do I buy Regeneron Pharmaceuticals (REGN) stock?
A

You can purchase shares of Regeneron Pharmaceuticals (NASDAQ: REGN) through any online brokerage.

View our list of the best stock brokerages.

Q
Who are Regeneron Pharmaceuticals's (REGN) competitors?
Q
What is the target price for Regeneron Pharmaceuticals (REGN) stock?
A

The latest price target for Regeneron Pharmaceuticals (NASDAQ: REGN) was reported by Canaccord Genuity on Friday, September 16, 2022. The analyst firm set a price target for 750.00 expecting REGN to rise to within 12 months (a possible 7.91% upside). 39 analyst firms have reported ratings in the last year.

Q
Current Stock Price for Regeneron Pharmaceuticals (REGN)?
A

The stock price for Regeneron Pharmaceuticals (NASDAQ: REGN) is $695.01 last updated September 27, 2022, 8:00 PM UTC.

Q
Does Regeneron Pharmaceuticals (REGN) pay a dividend?
A

There are no upcoming dividends for Regeneron Pharmaceuticals.

Q
When is Regeneron Pharmaceuticals (NASDAQ:REGN) reporting earnings?
A

Regeneron Pharmaceuticals’s Q3 earnings are confirmed for Thursday, November 3, 2022.

Q
Is Regeneron Pharmaceuticals (REGN) going to split?
A

There is no upcoming split for Regeneron Pharmaceuticals.

Q
What sector and industry does Regeneron Pharmaceuticals (REGN) operate in?
A

Regeneron Pharmaceuticals is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.